Pharmaceuticals, Biotechnology and Life Sciences
Moderna recieved second rare disease program to receive Fast Track designation with mRNA-3927, which uses the same proprietary LNP formulation as…
Disarm Therapeutics has presented at Neuroscience 2019 that its novel small molecule SARM1 inhibitors reproduce the axonal protection phenotype seen…
Progenity has named new Chief Commercial Officer, boosting its capacity in executive leadership team.
Phillips-Medisize has won a contract to produce first electronic-enabled combination drug delivery product, which is a post-phase 3 developement stage…
RALEIGH, N.C.–(BUSINESS WIRE)– SignalPath, a healthcare technology company reimagining the execution of clinical trials, announces the closing of their Series…
PRINCETON, N.J. & SAN DIEGO–(BUSINESS WIRE)–Sonnet BioTherapeutics Inc., a clinical stage biopharmaceutical developing innovative targeted biologic drugs, announced today that…
NOTTINGHAM, England–(BUSINESS WIRE)–Quotient Sciences, the innovative drug development and manufacturing organization, today announces the appointment of Claes Glassell as non-executive…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#AI— Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company developing oral small molecules for oncology and inflammatory…
– First Five Patients Enrolled into Study, Reaching 25% Completion of Targeted Enrollment – CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp.…